Liver Cancer Trial, Recruiting NCT04657042 Sponsor: University of Virginia Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT04657042
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with lung or liver cancer:

  • People aged 21 or older
  • People who have a primary or secondary (spread-from-elsewhere) tumour located in the lungs or liver
  • People whose tumour(s) measure less than 7 cm across
  • People whose treating radiation specialist has already planned for them to receive radiation therapy as part of their treatment
  • People whose treating radiation specialist has already planned for them to have a specific type of CT planning scan that tracks tumour movement (called a 4D-CT scan)
  • People who have given written consent and are willing to follow the imaging steps required by this study, which involve 4D-MRI scans

For healthy volunteers (no cancer required):

  • People aged 18 or older
  • People who have given written consent and are willing to follow the imaging steps required by this study, which involve 4D-MRI scans

Who may not be able to join:

  • People for whom an MRI scan is not medically safe — for example, those who have metal objects in their body such as a pacemaker, certain surgical clips, shrapnel, or similar devices
  • People who have difficulty lying flat on their back for a longer period of time
  • People living with serious or poorly managed physical or mental health conditions that could make it hard to follow the study's steps
  • People whose body size does not allow them to fit safely within the MRI scanner equipment
  • People who experience claustrophobia (fear of enclosed spaces)
  • People who are currently pregnant or breastfeeding
  • People who have an active or ongoing infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: G. Wilson Miller, PhD, Univsersity of Virginia

Phone: 4342436074

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 November 2020
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Image quality metrics in healthy volunteers; Image quality metrics in cancer patients; DVF errors in healthy volunteers and cancer patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov